Skip to main content
Caplight Logo









Heuristik

Heuristik

Private
GranadaHealthcare & Life Scienceshttps://heuristik.com/

Last Round

Pre Seed

Dec 15, 2025

Total Funding Raised

$2.31M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Heuristik operates in Healthcare & Life Sciences and is based in Granada. Its latest recorded funding round was a Pre Seed round in December 2025.

Heuristik is a HealthTech company that develops AI-powered biometric identification technology for healthcare settings to improve patient safety and management efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Digital Identity, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Heuristik Comparables

Compare Heuristik with similar companies based on industry and business-model similarity.

Heuristik comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ASSA ABLOY
64%
MYSPHERA
62%
Experian
62%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Heuristik Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 15, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Heuristik Investors

Notable investors and investment history

Heuristik investors
InvestorRounds
Spanish Society for Technological TransformationPre Seed
StartupxplorePre Seed
FundalogyPre Seed
VenturadePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2025

    $2.3M raised from Venturade and Fundalogy.

Book a demo to see all signals

For institutional investors. Book with your work email.

Heuristik Filings

Explore SEC and related filing metadata, where available.

Heuristik filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Heuristik's valuation, stock price, and market status.

Is Heuristik a public or private company?

Heuristik is a private company.

What is the current stock price of Heuristik?

Heuristik is a private company, so its shares have no public market price. Caplight tracks Heuristik's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Heuristik worth (valuation)?

Valuation information for Heuristik is not publicly available.

Can I buy Heuristik stock?

Heuristik shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Heuristik's last funding round?

Heuristik's most recent funding round was Pre Seed on December 15, 2025.

Who are the main investors in Heuristik?

Key investors in Heuristik include Spanish Society for Technological Transformation, Startupxplore, Fundalogy, Venturade.

Will Heuristik IPO soon?

No public IPO plans have been announced for Heuristik.

How can I track Heuristik secondary market activity?

Caplight tracks bids, offers, and trades in Heuristik's shares on secondary markets.

Firmographic Details

HeadquartersGranada
Year Founded2019
Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?